151 related articles for article (PubMed ID: 31476404)
21. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker.
Yang Y; Rhodus NL; Ondrey FG; Wuertz BR; Chen X; Zhu Y; Griffin TJ
PLoS One; 2014; 9(4):e95389. PubMed ID: 24748380
[TBL] [Abstract][Full Text] [Related]
22. Enhancing the developmental competence of the early embryo using secretory leukocyte peptidase inhibitor.
Kim HS; Ha KS; Kwon HC; Lee SJ; Kim CH; Cheon YP
Differentiation; 2016; 92(1-2):24-34. PubMed ID: 26927923
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
24. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics analysis of prognostic value of
Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
[No Abstract] [Full Text] [Related]
26. Cleaved SLPI, a novel biomarker of chymase activity.
Belkowski SM; Masucci J; Mahan A; Kervinen J; Olson M; de Garavilla L; D'Andrea MR
Biol Chem; 2008 Sep; 389(9):1219-24. PubMed ID: 18713008
[TBL] [Abstract][Full Text] [Related]
27. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
[TBL] [Abstract][Full Text] [Related]
28. miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.
Quabius ES; Merz I; Görögh T; Hedderich J; Haag J; Röcken C; Ambrosch P; Hoffmann M
Papillomavirus Res; 2017 Dec; 4():26-34. PubMed ID: 29179866
[TBL] [Abstract][Full Text] [Related]
29. Clobetasol down-regulates SLPI expression in U937 monocytoid cells.
Okumura N; Yoshida H; Kitagishi Y; Nishimura Y; Matsuda S
Int J Mol Med; 2012 Feb; 29(2):324-6. PubMed ID: 22076618
[TBL] [Abstract][Full Text] [Related]
30. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.
Wang X; Jin Y; Li YX; Yang Y
Oncol Rep; 2018 Apr; 39(4):1793-1804. PubMed ID: 29436667
[TBL] [Abstract][Full Text] [Related]
31. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
[TBL] [Abstract][Full Text] [Related]
32. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
33. Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis.
Shimoya K; Moriyama A; Ogata I; Nobunaga T; Koyama M; Azuma C; Murata Y
Mol Hum Reprod; 2000 Sep; 6(9):829-34. PubMed ID: 10956555
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of secretory leucocyte protease inhibitor in colon carcinoma].
Guo J; Li G; Zhuang J; Ji C; Liu F; Tao G; Dong H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):898-901. PubMed ID: 23803207
[TBL] [Abstract][Full Text] [Related]
35. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
Zhang X; Liu SS; Ma J; Qu W
Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
[TBL] [Abstract][Full Text] [Related]
36. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
[TBL] [Abstract][Full Text] [Related]
38. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
39. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells.
Velarde MC; Parisek SI; Eason RR; Simmen FA; Simmen RC
J Endocrinol; 2005 Jan; 184(1):141-51. PubMed ID: 15642791
[TBL] [Abstract][Full Text] [Related]
40. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.
Quabius ES; Görögh T; Fischer GS; Hoffmann AS; Gebhard M; Evert M; Beule A; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Röcken C; Hedderich J; Ambrosch P; Hoffmann M
Cancer Lett; 2015 Feb; 357(1):339-345. PubMed ID: 25462861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
